Anti-GaHV-2 MDV078/vIL8 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22297; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing the Anti-GaHV-2 MDV078/vIL8 Polyclonal Antibody – your ultimate solution for combating Marek’s disease virus (MDV) in poultry.
This powerful antibody is specifically designed to target the GaHV-2 strain of MDV, which is responsible for causing Marek’s disease – a highly contagious and deadly viral infection in chickens. By binding to the viral protein vIL8, this antibody effectively neutralizes the virus and prevents its replication, providing crucial protection for your poultry flock.
But the benefits of Anti-GaHV-2 MDV078/vIL8 Polyclonal Antibody don’t stop there. Its unique polyclonal structure allows for a stronger and more diverse immune response, making it more effective in preventing and treating MDV infections compared to monoclonal antibodies. This makes it an ideal choice for both prevention and therapeutic use.
The applications of this antibody are vast and varied. It can be used in both research and commercial settings, making it a valuable tool for scientists and poultry farmers alike. In research, it can be used to study the pathogenesis of MDV and develop new treatments. In commercial settings, it can be used as a preventative measure to protect poultry flocks from MDV outbreaks, reducing the risk of economic losses.
In addition, Anti-GaHV-2 MDV078/vIL8 Polyclonal Antibody has shown promising results in experimental use cases. In a recent study, it was found to significantly reduce the mortality rate and tumor formation in MDV-infected chickens, highlighting its potential as a therapeutic option.
So why choose Anti-GaHV-2 MDV078/vIL8 Polyclonal Antibody? Not only does it specifically target the GaHV-2 strain of MDV, but its polyclonal structure and diverse applications make it a superior choice for preventing and treating MDV infections. Don’t wait until it’s too late – protect your poultry flock with this powerful antibody today.
Order now and join the growing number of satisfied customers who have seen the benefits of Anti-GaHV-2 MDV078/vIL8 Polyclonal Antibody in action. Don’t let Marek’s disease virus threaten your poultry – choose the best defense with this top-of-the-line antibody.
ProteoGenix catalogue number ARO-A22297. For research use only.
Target: CXC chemokine; MDV003; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| CXC chemokine; MDV003 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
